Position
Creative Planning in Dyne Therapeutics, Inc.
Back to the book · All holders of DYN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$28.3K$19.56 → $18.13
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 19.8K | $386.7K | — | — | — | 0.0% |
| Q1 2026 | 29.9K | $542.9K | $18.13 | −$28.3K | $184.5K | 0.0% |